BRUNO, Savino
 Distribuzione geografica
Continente #
NA - Nord America 627
EU - Europa 99
AS - Asia 58
AF - Africa 14
Totale 798
Nazione #
US - Stati Uniti d'America 613
CN - Cina 40
FI - Finlandia 24
DE - Germania 15
IE - Irlanda 15
CA - Canada 14
NG - Nigeria 14
BE - Belgio 12
IL - Israele 12
FR - Francia 9
SE - Svezia 8
IT - Italia 6
NL - Olanda 4
SG - Singapore 3
DK - Danimarca 2
GB - Regno Unito 2
TR - Turchia 2
IM - Isola di Man 1
IN - India 1
RO - Romania 1
Totale 798
Città #
Chandler 161
Wilmington 99
Shanghai 39
Ann Arbor 33
San Mateo 32
Boardman 31
New York 26
Ashburn 24
Helsinki 24
Leawood 24
Lawrence 15
Princeton 15
Benin City 14
Dublin 14
Toronto 13
Brussels 12
Paris 9
Woodbridge 7
Fairfield 6
Amsterdam 4
Falls Church 3
Milan 3
San Diego 3
Singapore 3
Falkenstein 2
Frankfurt am Main 2
Kocaeli 2
London 2
Norwalk 2
Santa Clara 2
Seattle 2
Torino 2
Apo 1
Clearwater 1
Des Moines 1
Douglas 1
Gorey 1
Gunzenhausen 1
Hangzhou 1
Houston 1
Iasi 1
Los Angeles 1
Media 1
Monmouth Junction 1
Pune 1
Redmond 1
Winnipeg 1
Totale 645
Nome #
Real life experiences in HCV management in 2018 65
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis 64
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 63
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 60
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population 59
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response 59
Role of Myeloid Cells in the Immunosuppressive Microenvironment in Gliomas 55
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 54
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65years with HCV genotype 1 cirrhosis 54
From current status to optimization of HCV treatment: Recommendations from an expert panel 53
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 53
Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class A liver cirrhosis 50
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 43
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 34
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 21
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 14
Toward precision medicine in primary biliary cholangitis 4
Totale 805
Categoria #
all - tutte 4.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021183 3 2 0 1 0 52 44 11 27 25 3 15
2021/2022119 1 3 1 18 6 3 12 13 6 10 32 14
2022/2023324 32 32 19 54 20 37 0 33 64 22 8 3
2023/2024177 14 12 29 21 8 36 28 17 4 3 5 0
Totale 805